亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Treatment of Hypertension

医学 坎德萨坦 氯沙利酮 氢氯噻嗪 血压 内科学 阿替洛尔 氨氯地平 钙通道阻滞剂 噻嗪 心脏病学 利尿剂 内分泌学 血管紧张素II
作者
Robert M. Carey,Andrew E. Moran,Paul K. Whelton
出处
期刊:JAMA [American Medical Association]
卷期号:328 (18): 1849-1849 被引量:140
标识
DOI:10.1001/jama.2022.19590
摘要

Importance Hypertension, defined as persistent systolic blood pressure (SBP) at least 130 mm Hg or diastolic BP (DBP) at least 80 mm Hg, affects approximately 116 million adults in the US and more than 1 billion adults worldwide. Hypertension is associated with increased risk of cardiovascular disease (CVD) events (coronary heart disease, heart failure, and stroke) and death. Observations First-line therapy for hypertension is lifestyle modification, including weight loss, healthy dietary pattern that includes low sodium and high potassium intake, physical activity, and moderation or elimination of alcohol consumption. The BP-lowering effects of individual lifestyle components are partially additive and enhance the efficacy of pharmacologic therapy. The decision to initiate antihypertensive medication should be based on the level of BP and the presence of high atherosclerotic CVD risk. First-line drug therapy for hypertension consists of a thiazide or thiazidelike diuretic such as hydrochlorothiazide or chlorthalidone, an angiotensin-converting enzyme inhibitor or angiotensin receptor blocker such as enalapril or candesartan, and a calcium channel blocker such as amlodipine and should be titrated according to office and home SBP/DBP levels to achieve in most people an SBP/DBP target (<130/80 mm Hg for adults <65 years and SBP <130 mm Hg in adults ≥65 years). Randomized clinical trials have established the efficacy of BP lowering to reduce the risk of CVD morbidity and mortality. An SBP reduction of 10 mm Hg decreases risk of CVD events by approximately 20% to 30%. Despite the benefits of BP control, only 44% of US adults with hypertension have their SBP/DBP controlled to less than 140/90 mm Hg. Conclusions and Relevance Hypertension affects approximately 116 million adults in the US and more than 1 billion adults worldwide and is a leading cause of CVD morbidity and mortality. First-line therapy for hypertension is lifestyle modification, consisting of weight loss, dietary sodium reduction and potassium supplementation, healthy dietary pattern, physical activity, and limited alcohol consumption. When drug therapy is required, first-line therapies are thiazide or thiazidelike diuretics, angiotensin-converting enzyme inhibitor or angiotensin receptor blockers, and calcium channel blockers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小王完成签到,获得积分10
6秒前
rofsc完成签到 ,获得积分10
12秒前
17秒前
鲤鱼凛发布了新的文献求助30
22秒前
23秒前
在水一方应助夹心大王采纳,获得10
25秒前
史国志完成签到 ,获得积分10
26秒前
鲤鱼凛发布了新的文献求助10
28秒前
鲤鱼凛完成签到,获得积分10
33秒前
okimi完成签到,获得积分10
33秒前
35秒前
胡大嘴先生完成签到,获得积分10
38秒前
zl发布了新的文献求助10
39秒前
41秒前
42秒前
44秒前
小王发布了新的文献求助10
45秒前
刘啊啊啊发布了新的文献求助10
48秒前
50秒前
小张完成签到 ,获得积分10
58秒前
彭彭发布了新的文献求助10
1分钟前
刘啊啊啊完成签到,获得积分20
1分钟前
1分钟前
夹心大王发布了新的文献求助10
1分钟前
1分钟前
lin完成签到 ,获得积分10
1分钟前
落后从阳发布了新的文献求助10
1分钟前
qsq完成签到 ,获得积分10
1分钟前
夹心大王完成签到,获得积分10
1分钟前
大模型应助落后从阳采纳,获得10
1分钟前
1分钟前
1分钟前
戒灵发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
zl发布了新的文献求助10
2分钟前
L_93完成签到,获得积分10
2分钟前
2分钟前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Bayesian Models of Cognition:Reverse Engineering the Mind 888
Le dégorgement réflexe des Acridiens 800
Defense against predation 800
XAFS for Everyone (2nd Edition) 600
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3133892
求助须知:如何正确求助?哪些是违规求助? 2784804
关于积分的说明 7768575
捐赠科研通 2440160
什么是DOI,文献DOI怎么找? 1297188
科研通“疑难数据库(出版商)”最低求助积分说明 624911
版权声明 600791